Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75

Barnes, 2020, SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies, Nature, 588, 682, 10.1038/s41586-020-2852-1 Chan, 2020, Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2, Science, 369, 1261, 10.1126/science.abc0870 Garrett, 2021, High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies, Cell, 184, 2927, 10.1016/j.cell.2021.04.045 Greaney, 2021, Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies, Cell Host Microbe, 29, 463, 10.1016/j.chom.2021.02.003 Greaney, 2021, Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies, Nat. Commun., 12, 4196, 10.1038/s41467-021-24435-8 Hansen, 2020, Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail, Science, 369, 1010, 10.1126/science.abd0827 Hong, 2022, Molecular basis of receptor binding and antibody neutralization of Omicron, Nature, 604, 546, 10.1038/s41586-022-04581-9 Iketani, 2022, Antibody evasion properties of SARS-CoV-2 Omicron sublineages, Nature, 604, 553, 10.1038/s41586-022-04594-4 Jones, 2021, The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates, Sci. Transl. Med., 13, eabf1906, 10.1126/scitranslmed.abf1906 Ju, 2020, Human neutralizing antibodies elicited by SARS-CoV-2 infection, Nature, 584, 115, 10.1038/s41586-020-2380-z Liu, 2022, An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses, Sci Transl Med, 584, eabn6859, 10.1126/scitranslmed.abn6859 Liu, 2022, Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2, Nature, 602, 676, 10.1038/s41586-021-04388-0 Liu, 2020, Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike, Nature, 584, 450, 10.1038/s41586-020-2571-7 Nutalai, 2022, Potent cross-reactive antibodies following Omicron breakthrough in vaccinees, Cell, 185, 2116, 10.1016/j.cell.2022.05.014 Pinto, 2020, Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody, Nature, 583, 290, 10.1038/s41586-020-2349-y Sheward, 2022, Structural basis of Omicron neutralization by affinity-matured public antibodies, bioRxiv Shi, 2020, A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2, Nature, 584, 120, 10.1038/s41586-020-2381-y Shu, 2017, GISAID: global initiative on sharing all influenza data - from vision to reality, Euro Surveill., 22, 30494, 10.2807/1560-7917.ES.2017.22.13.30494 Starr, 2021, SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape, Nature, 597, 97, 10.1038/s41586-021-03807-6 Wang, 2022, Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants, Nature, 603, 919, 10.1038/s41586-022-04466-x Wang, 2021, Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants, Science, 373, eabh1766, 10.1126/science.abh1766 Wang, 2022, Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5, Nature, 608, 603, 10.1038/s41586-022-05053-w Wang, 2022, 35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope, Cell Host Microbe, 30, 887, 10.1016/j.chom.2022.03.035 Wang, 2022, Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins, Immunity, 55, 998, 10.1016/j.immuni.2022.04.003 Westendorf, 2022, LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants, Cell Rep., 39, 110812, 10.1016/j.celrep.2022.110812 Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367, 1260, 10.1126/science.abb2507 Yin, 2022, Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody, Science, 375, 1048, 10.1126/science.abn8863 Zhou, 2022, A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge, Nat. Commun., 13, 3589, 10.1038/s41467-022-31259-7 Zost, 2020, Potently neutralizing and protective human antibodies against SARS-CoV-2, Nature, 584, 443, 10.1038/s41586-020-2548-6